文献速递类风湿关节炎

一组血浆微小RNA改善类风湿关节炎患者心血管疾病替代标志物的评估

A panel of plasma microRNAs improves the assessment of surrogate markers of cardiovascular disease in rheumatoid arthritis patients.
PubMed 文献 · Rheumatology (Oxford) · 2023-01-01

纳入199例类风湿关节炎患者,检测10种血浆微小RNA与亚临床动脉硬化替代标志物的关联。多变量模型显示微小RNA-24、125a、132、146、191、223与颈动脉内中膜厚度相关,微小RNA-24、146、Let7a与男性颈动脉斑块相关,微小RNA-96与男性脉搏波速度相关。作者认为这些微小RNA可能预测类风湿关节炎患者的心血管风险。

要点

  • 微小RNA-24、125a、132、146、191、223与类风湿关节炎患者颈动脉内中膜厚度相关。
  • 男性中微小RNA-24、146、Let7a与颈动脉斑块存在关联。
  • 微小RNA-96与男性脉搏波速度相关,高DAS28组和病程早期组亦见关联。

核心结论

  • 血浆微小RNA-24、96、103、125a、132、146、191、223和Let7a与心血管疾病替代标志物相关,可能预测类风湿关节炎患者的心血管风险。

研究设计与样本

  • 纳入199例类风湿关节炎患者,用My Lab 60 X-Vision超声仪测量动脉硬化替代标志物,从血浆提取微小RNA并用qPCR定量,采用多变量模型和分类方法分析。

主要发现

  • 多变量模型显示微小RNA-24(β=15.48)、125a(β=9.93)、132(β=11.52)、146(β=15.12)、191(β=13.25)和223(β=13.30)与整体颈动脉内中膜厚度相关。
  • 男性中微小RNA-24(OR=0.41)、146(OR=0.36)和Let7a(OR=0.23)与颈动脉斑块存在关联。
  • 将微小RNA纳入偏最小二乘判别分析模型可正确分类有和无颈动脉斑块的男性。
  • 男性患者中微小RNA-96(β=-0.28)与脉搏波速度相关。
  • 高DAS28组和病程早期三分位组中,多种微小RNA与颈动脉内中膜厚度、颈动脉斑块和动脉僵硬度相关。

关键数值与推荐

  • 微小RNA-24与颈动脉斑块的OR=0.41,微小RNA-146的OR=0.36,Let7a的OR=0.23,均为男性患者中的关联。
  • 微小RNA-24的β=15.48、125a的β=9.93、132的β=11.52、146的β=15.12、191的β=13.25、223的β=13.30,均与整体颈动脉内中膜厚度相关。
  • 微小RNA-96与男性脉搏波速度的β=-0.28。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with RA present increased risk of cardiovascular (CV) disease compared with the general population. Moreover, CV risk factors that have a causal relationship with atherosclerosis do not seem to fully explain the accelerated process that they exhibit. We evaluated the association of a 10 microRNAs panel with surrogate markers of subclinical arteriosclerosis [carotid intima-media thickness (cIMT), carotid plaque presence (cPP), pulse wave velocity (PWV) and distensibility] in a cohort of RA patients. MATERIAL AND METHODS: A total of 199 patients with RA were included. Surrogate markers of arteriosclerosis were measured with My Lab 60 X-Vision sonographer. MicroRNAs were extracted from plasma and quantified with qPCR. Multivariate models and classification methods were performed. RESULTS: Multivariate models showed that microRNAs-24 (β = 15.48), 125a (β = 9.93), 132 (β = 11.52), 146 (β = 15.12), 191 (β = 13.25) and 223 (β = 13.30) were associated with cIMT globally. MicroRNA-24 [odds ratio (OR) = 0.41], 146 (OR = 0.36) and Let7a (OR = 0.23) were associated with cPP in men. Including the microRNAs in a partial least square discriminant analysis model properly classified men with and without cPP. MicroRNA-96 (β = -0.28) was associated with PWV in male patients. Finally, several miRNAs were also associated with cIMT, cPP and arterial stiffness in the high DAS28 group and in the earlier tertile groups of disease duration. CONCLUSION: Plasmatic expression of microRNA-24, 96, 103, 125a, 132, 146, 191, 223 and Let7a were associated with surrogate markers of CV disease and could be predictors of CV risk in patients with RA.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Llop D, Ibarretxe D, Plana N, et al. A panel of plasma microRNAs improves the assessment of surrogate markers of cardiovascular disease in rheumatoid arthritis patients. Rheumatology (Oxford). 2023. PMID: 36048908. doi:10.1093/rheumatology/keac483

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。